Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(50.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
4Total
Phase 1(2)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00926627Phase 2Terminated

Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis

Role: lead

NCT01768507Not ApplicableCompleted

Reresveratrol Administered to Healthy Male Subjects

Role: lead

NCT00895167Phase 1Completed

The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects

Role: lead

NCT00682370Phase 1Completed

Effects of Heme Arginate in Healthy Male Subjects

Role: lead

All 4 trials loaded